Literature DB >> 10393849

Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.

N Ishimaru1, K Saegusa, K Yanagi, N Haneji, I Saito, Y Hayashi.   

Abstract

Estrogenic action has been suggested to be responsible for the strong female preponderance of autoimmune diseases, but the role of estrogens in the female has not been well characterized. We evaluated the effects of estrogen deficiency in a murine model for autoimmune exocrinopathy of Sjögren's syndrome (SS). Severe destructive autoimmune lesions developed in the salivary and lacrimal glands in estrogen-deficient mice, and these lesions were recovered by estrogen administration. We detected an intense estrogen receptor in splenic CD8(+) T cells compared with that in CD4(+) T cells, and concanavalin-A-stimulated blastogenesis of splenic CD8(+) T cells with estrogens was much higher than that of CD4(+) T cells. We found a significant increase in serum autoantibody production against the organ-specific autoantigen alpha-fodrin. Moreover, an increased proportion of TUNEL+ apoptotic epithelial duct cells was observed in estrogen-deficient mice. It was demonstrated that Fas-mediated apoptosis in cultured salivary gland cells was clearly inhibited by estrogens in vitro. These results indicate that dysfunction of regulatory T cells by estrogen deficiency may play a crucial role on acceleration of organ-specific autoimmune lesions, and estrogenic action further influences target epithelial cells through Fas-mediated apoptosis in a murine model for SS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393849      PMCID: PMC1866653          DOI: 10.1016/S0002-9440(10)65111-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

Review 1.  The immune-hypothalamic-pituitary-adrenal axis.

Authors:  A Bateman; A Singh; T Kral; S Solomon
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

Review 2.  T cell receptors in murine autoimmune diseases.

Authors:  H Acha-Orbea; L Steinman; H O McDevitt
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Clonal dominance among T-lymphocyte infiltrates in arthritis.

Authors:  I Stamenkovic; M Stegagno; K A Wright; S M Krane; E P Amento; R B Colvin; R J Duquesnoy; J T Kurnick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 4.  Effects of gender and sex steroids on the immune response.

Authors:  A H Schuurs; H A Verheul
Journal:  J Steroid Biochem       Date:  1990-02       Impact factor: 4.292

5.  Differential distribution of an estrogen receptor in the submandibular and parotid salivary glands of female rats.

Authors:  P S Campbell; H Ben-Aryeh; K A Swanson
Journal:  Endocr Res       Date:  1990       Impact factor: 1.720

6.  Estrogen regulates the IFN-gamma promoter.

Authors:  H S Fox; B L Bond; T G Parslow
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

7.  Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.

Authors:  M M Gottardis; M E Ricchio; P G Satyaswaroop; V C Jordan
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

8.  Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome.

Authors:  A C Vendramini; C Soo; D A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-10       Impact factor: 4.799

Review 9.  Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis.

Authors:  C Grossman
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

10.  A new mutation involving the sublingual gland in NFS/N mice. Partially arrested mucous cell differentiation.

Authors:  Y Hayashi; A Kojima; M Hata; K Hirokawa
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

View more
  28 in total

1.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.

Authors:  K Saegusa; N Ishimaru; K Yanagi; N Haneji; M Nishino; M Azuma; I Saito; Y Hayashi
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.

Authors:  Tetsuya Akaishi; Toshiyuki Takahashi; Kazuo Fujihara; Tatsuro Misu; Juichi Fujimori; Yoshiki Takai; Shuhei Nishiyama; Michiaki Abe; Tadashi Ishii; Masashi Aoki; Ichiro Nakashima
Journal:  J Neurol       Date:  2021-01-08       Impact factor: 4.849

5.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.

Authors:  Jennifer Y Barr; Xiaofang Wang; Portia A Kreiger; Scott M Lieberman
Journal:  Immunology       Date:  2018-05-31       Impact factor: 7.397

7.  Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.

Authors:  Gil-Jin Shim; Margaret Warner; Hyun-Jin Kim; Sandra Andersson; Lining Liu; Jenny Ekman; Otabek Imamov; Margaret E Jones; Evan R Simpson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

9.  Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background.

Authors:  Rieko Arakaki; Ai Nagaoka; Naozumi Ishimaru; Akiko Yamada; Satoko Yoshida; Yoshio Hayashi
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

10.  Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Journal:  Lab Invest       Date:  2010-01-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.